NFKB1 and neoplasm: Mice that received UBCS039 presented significantly greater expression of the Sirt6, NF-kB, PD-1 and PD-L1 mRNAs in tumor tissue than did mice that received either DMSO or PBS pretreatment (Fig. 5).